Bank Julius Baer & Co
IART icon

Bank Julius Baer & Co’s Integra LifeSciences IART Stock Holding History

Bank Julius Baer & Co’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-693
Closed -$45K – 854
2020
Q4 		$45K Buy
+693
New +$37.3K ﹤0.01% 694

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank Julius Baer & Co's IART Position: Q1 2021 in Review

Bank Julius Baer & Co sold out of Integra LifeSciences (IART) in Q1 2021, closing a stake of 693 shares — an estimated $45K sold.

Bank Julius Baer & Co first reported a position in IART in Q4 2020 and held it in 1 quarter. The position peaked at $45K in Q4 2020. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

  • Bank Julius Baer & Co reported no remaining Integra LifeSciences position as of Q1 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 693 Integra LifeSciences shares in Q1 2021, an estimated $45K.
  • Bank Julius Baer & Co first reported a position in Integra LifeSciences in Q4 2020 and held it in 1 quarter.
  • Bank Julius Baer & Co's Integra LifeSciences position peaked at $45K in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.